| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.75 | 0.3 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |